Akero Therapeutics Aktie
WKN DE: A2PLNP / ISIN: US00973Y1082
12.05.2025 13:17:12
|
Akero Therapeutics Inc. Loss At -$70.73 Mln In Q1
(RTTNews) - Akero Therapeutics Inc. (AKRO) reported Loss for first quarter of -$70.73 million
The company's earnings came in at -$70.73 million, or -$0.90 per share. This compares with -$53.34 million, or -$0.90 per share, last year.
Akero Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$70.73 Mln. vs. -$53.34 Mln. last year. -EPS: -$0.90 vs. -$0.90 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Akero Therapeutics Inc Registered Shs Accred Invmehr Nachrichten
Analysen zu Akero Therapeutics Inc Registered Shs Accred Invmehr Analysen
Aktien in diesem Artikel
Akero Therapeutics Inc Registered Shs Accred Inv | 41,61 | 1,54% |
|